CIBC Asset Management Inc
Position in RGC — Regencell Bioscience Holdings Ltd
CIK 1021926
Toronto, A6
Position in RGC
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$93,128
New position
Shares Held
15,292
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 35 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CIBC Asset Management Inc holds $28,653,269 across 17 Drug Manufacturers - Specialty & Generic names. RGC ranks #16 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
119,627 | $8,596,396 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
159,286 | $5,396,609 | |
| 3 | VTRS |
Viatris Inc
|
255,729 | $4,060,976 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
6,285 | $3,405,401 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
19,103 | $3,219,619 | |
| 6 | BHC |
Bausch Health Companies Inc.
|
265,310 | $1,307,978 | |
| 7 | HLN |
Haleon plc
|
60,500 | $564,465 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
15,695 | $386,253 |
All Filings in RGC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $93,128 | 15,292 | Shares | Sole | 2026-08-03 | |
| No filing history on record for this holder in this stock. | ||||||